Package 0173-0681-01

{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "244881b7-a19f-4409-abf7-2df6ad39c28e", "openfda": {"nui": ["N0000175524", "N0000175436"], "unii": ["L6O3XI777I"], "rxcui": ["759471", "759473"], "spl_set_id": ["d7c3bcc3-0c0d-4068-fd80-88cf54a376ef"], "pharm_class_epc": ["Neuraminidase Inhibitor [EPC]"], "pharm_class_moa": ["Neuraminidase Inhibitors [MoA]"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 PACKAGE in 1 CARTON (0173-0681-01)  / 4 POWDER in 1 PACKAGE", "package_ndc": "0173-0681-01", "marketing_start_date": "19990922"}, {"sample": false, "description": "5 PACKAGE in 1 CARTON (0173-0681-22)  / 4 POWDER in 1 PACKAGE", "package_ndc": "0173-0681-22", "marketing_start_date": "20070309"}], "brand_name": "RELENZA", "product_id": "0173-0681_244881b7-a19f-4409-abf7-2df6ad39c28e", "dosage_form": "POWDER", "pharm_class": ["Neuraminidase Inhibitor [EPC]", "Neuraminidase Inhibitors [MoA]"], "product_ndc": "0173-0681", "generic_name": "zanamivir", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RELENZA", "active_ingredients": [{"name": "ZANAMIVIR", "strength": "5 mg/1"}], "application_number": "NDA021036", "marketing_category": "NDA", "marketing_start_date": "19990922", "listing_expiration_date": "20261231"}